
Valeant Pharmaceuticals has published its results for the first quarter, which has seen the firm post a net loss of …
2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

